Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: A comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns

Critical Care Medicine

Volumn 28, Issue 4, 2000, Pages 969-976

  Kienbaum, Peter ^a   Scherbaum, Norbert ^a   Thürauf, Norbert ^a   Michel, Martin C ^a   Gastpar, Markus ^a   Peters, Jürgen ^a  

^a NONE

Author keywords

Cardiovascular stimulation; Catecholamine plasma concentration; Hemodynamic monitoring; Methohexital anesthesia; Opioid addiction; Opioid detoxification; Oxygen consumption; Propofol anesthesia; Short Opiate Withdrawal Scale; opioid receptor antagonization

Indexed keywords

ADRENALIN; ARPILON; CATECHOLAMINE; CLONIDINE; KLIMOFOL; METHADONE; METHOHEXITAL; MU OPIATE RECEPTOR; NALOXONE; NORADRENALIN; OPIATE; OXYGEN; PIPECURONIUM; PROPOFOL;

ADULT; ARTICLE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXTUBATION; FEMALE; GENERAL ANESTHESIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METABOLISM; NEUROENDOCRINE SYSTEM; OPIATE ADDICTION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WITHDRAWAL SYNDROME;

EID: 0034061662     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200004000-00010     Document Type: Article

References (44)

1. 1. Loimer N, Schmid RW, Presslich O, et al: Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment. J Psychiatr Res 1989; 23:81-86
2. 2. Loimer N, Schmid R, Lenz K, et al: Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone. Br J Psychiatry 1990; 157:748-752
3. 3. Loimer N, Hofmann P, Chaudhry H: Ultra-short noninvasive opiate detoxification. Am J Psychiatry 1993; 150:839
4. 4. Legarda JJ, Gossop M: A 24-h inpatient detoxification treatment for heroin addicts: A preliminary investigation. Drug Alcohol Depend 1994; 35:91-93
5. 5. O'Connor PG, Kosten TR: Rapid and ultra-rapid opioid detoxification techniques. JAMA 1998; 279:229-234
6. 6. Brewer C, Rezae H, Bailey C: Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique. Br J Psychiatry 1988; 153:340-343
7. 7. Strang J, Bearn J, Gossop M: Opiate detoxification under anaesthesia. BMJ 1997; 315: 1249-1250
8. 8. Gonzalez JP, Brogden RN: Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs 1988; 35:192-213
9. 9. Garcia-Alonso F, Gutierrez M, San J, et al: A multicentre study to introduce naltrexone for opiate dependence in Spain. Drug Alcohol Depend 1989; 23:117-121
10. 10. Kienbaum P, Thürauf N, Michel MC, et al: Profound increase in epinephrine concentration in plasma and cardiovascular stimulation following mu-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification. Anesthesiology 1998; 88:1154-1161
11. 11. Bauch H-J, Kelsch U, Hauss WH: Einfache, schnelle, selektive und quantitative Bestimmung von Adrenalin und Noradrenalin im Plasma durch Kombination von Flüssigkeitsextraktion, HPLC-Trennung und elektrochemischer Detektion. J Clin Chem Clin Biochem 1986; 24:651-658
12. 12. Gossop M: The development of a Short Opiate Withdrawal Scale (SOWS). Addict Behav 1990; 15:487-490
13. 13. Gossop M, Strang J: A comparison of the withdrawal responses of heroin and methadone addicts during detoxification. Br J Psychiatry 1991; 158:697-699
14. 14. Taff RH: Pulmonary edema following low-dose naloxone administration in a patient without heart disease. Anesthesiology 1983; 59:576-577
15. 15. Partridge BL, Ward CF: Pulmonary edema following low-dose naloxone administration. Anesthesiology 1986; 65:709-710
16. 16. Johnson C, Mayer P, Grosz D: Pulmonary edema following naloxone administration in a healthy orthopedic patient. J Clin Anesth 1995; 7:356-357
17. 17. Pfab T, Hirtl C, Hibler A, et al: Der Antagonist-induzierte, Narkose-gestützte Opiat-Schnellentzug (AINOS). Münch Med Wochenschr 1996; 138:781-786
18. 18. Liang K-Y, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22
19. 19. Ramsay MA, Savege TM, Simpson BR, et al: Controlled sedation with alphaxalone-alphadolone. Br Med J 1974; 2:656-659
20. 20. Becker KE Jr, Tonnesen AS: Cardiovascular effects of plasma levels of thiopental necessary for anesthesia. Anesthesiology 1978; 49: 197-200
21. 90 induction doses in pediatric anesthesia. Rev Esp Anestesiol Reanim 1994; 41:152-155
22. 22. Gustafsson LL, Ebling WF, Osaki E, et al: Quantitation of depth of thiopental anesthesia in the rat. Anesthesiology 1996; 84: 415-427
23. 23. Peiss CN, Manning JW: Effects of sodium pentobarbital on electrical and reflex activation of the cardiovascular system. Circ Res 1964; 14:228-235
24. 24. Inoue K, Arndt JO: Efferent vagal discharge and heart rate in response to methohexitone, althesin, ketamine and etomidate in cats. Br J Anaesth 1982; 54:1105-1116
25. 25. Best SC, Oliveto AH, Kosten TR: Opioid addiction. Recent advances in detoxification and maintenance therapy. CNS Drugs 1996; 6:301-314
26. 26. Mattick RP, Hall W: Are detoxification programs effective? Lancet 1996; 347:97-100
27. 27. Estilo AE, Cottrell JE: Hemodynamic and catecholamine changes after administration of naloxone. Anesth Analg 1982; 61:349-353
28. 28. Wallin BG, König U: Changes of skin nerve sympathetic activity during induction of general anesthesia with thiopentone in man. Brain Res 1976; 103:157-160
29. 29. Ebert TJ, Kanitz DD, Kampine JP: Inhibition of sympathetic neural outflow during thiopental anesthesia in humans. Anesth Analg 1990; 71:319-326
30. 30. Sellgren J, Ponten J, Wallin BG: Percutaneous recording of muscle nerve sympathetic activity during propofol, nitrous oxide, and isoflurane anesthesia in humans. Anesthesiology 1990; 73:20-27
31. 31. Ebert TJ, Muzi M: Propofol and autonomic reflex function in humans. Anesth Analg 1994; 78:369-375
32. 32. Sellgren J, Ejnell H, Elam M, et al: Sympathetic muscle nerve activity, peripheral blood flows, and baroreceptor reflexes in humans during propofol anesthesia and surgery. Anesthesiology 1994; 80:534-544
33. 33. Delle M, Ricksten SE, Haggendal J, et al: Regional changes in sympathetic nerve activity and baroreceptor reflex function and arterial plasma levels of catecholamines, renin and vasopressin during naloxone-precipitated morphine withdrawal in rats. J Pharmacol Exp Ther 1990; 253:646-654
34. 34. Chang AP, Dixon WR: Role of plasma catecholamines in eliciting cardiovascular changes seen during naloxone-precipitated withdrawal in conscious, unrestrained morphine-dependent rats. J Pharmacol Exp Ther 1990; 254:857-863
35. 35. Ensinger H, Weichel T, Lindner KH, et al: Effects of norepinephrine, epinephrine, and dopamine infusions on oxygen consumption in volunteers. Crit Care Med 1993; 21:1502-1508
36. 36. Stratton JR, Pfeifer MA, Ritcher JL, et al: Hemodynamic effects of epinephrine: Concentration-effect study in humans. J Appl Physiol 1985; 58:1199-1206
37. 37. Sellgren J, Ponten J, Wallin BG: Characteristics of muscle nerve sympathetic activity during general anaesthesia in humans. Acta Anaesthesiol Scand 1992; 36:336-345
38. 38. Dettling M, Tretter F: Der Opiatentzug in Narkose (forcierter Narkoseentzug. "Turboentzug") bei Opiatabhängigkeit. Nervenarzt 1996; 67:805-810
39. 39. Doze VA, Westphal LM, White PF: Comparison of propofol with methohexital for outpatient anesthesia. Anesth Analg 1986; 65:1189-1195
40. 40. Albanese J, Martin C, Lacarelle B, et al: Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients. Anesthesiology 1990; 73:214-217
41. 41. Price DE, Mehta A, Park BK, et al: The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction. Br J Clin Pharmacol 1986; 22:744-747
42. 42. Perry SM, Whelan E, Shay S, et al: Effect of i.v. anaesthesia with propofol on drug distribution and metabolism in the dog. Br J Anaesth 1991; 66:66-72
43. 43. Baker MT, Chadam MV, Ronnenberg WC Jr: Inhibitory effects of propofol on cytochrome P450 activities in rat hepatic microsomes. Anesth Analg 1993; 76:817-821
44. 44. Darda S, Forster HJ, Sthle H: Metabolic degradation of clonidine. Arzneimittelforschung 1978; 28:255-259